shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
MIK-ENA-37e0b697,Z5597290783,C24H21ClN4O3,Single unknown enantiomer,448.901,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-91,03_A,"CNC(=O)CN1C[C@]2(CCN(C2=O)C=3C=NC=C4C=CC=CC34)C=5C=C(Cl)C=CC5C1=O |o1:7,r|","rel-2-[(4R)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3695008,1.1
MIK-ENA-794411b8,Z5597290820,C24H21ClN4O3,Single unknown enantiomer,448.901,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-91,03_B,"CNC(=O)CN1C[C@@]2(CCN(C2=O)C=3C=NC=C4C=CC=CC34)C=5C=C(Cl)C=CC5C1=O |o1:7,r|","rel-2-[(4R)-6-chloro-1'-(isoquinolin-4-yl)-1,2'-dioxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3695009,2.7
ALP-POS-ecbed2ba-15,Z5461592490,C28H27ClN4O3S,Racemic or presumed racemic or meso,535.056,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-91,03_C,ClC=1C=CC=2CN(CC3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C2C1)S(=O)(=O)CC6(CCCC6)C#N,"1-({[6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopentane-1-carbonitrile",H3755416,11.1
ALP-POS-ecbed2ba-17,Z5461592497,C24H22ClN5O3S,Racemic or presumed racemic or meso,495.981,95,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-91,03_D,CN(CC#N)S(=O)(=O)N1CC=2C=CC(Cl)=CC2C3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C1,"2-({[6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}(methyl)amino)acetonitrile",H3745390,0.7
MAT-POS-38eb6498-3,Z5631110235,C28H32ClN5O3,Racemic or presumed racemic or meso,522.038,95,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-91,03_E,CNC(=O)CN1CC=2C=CC(Cl)=CC2C3(CCN(C3=O)C=4C=NC=C5C=CC(OCCN(C)C)=CC45)C1,"2-(6-chloro-1'-{6-[2-(dimethylamino)ethoxy]isoquinolin-4-yl}-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl)-N-methylacetamide",H3756545,3.4
